Sanders takes aim at US drug prices of Novo’s Ozempic and Wegovy
Senator Bernie Sanders has targeted the high drug prices of Novo Nordisk’s Ozempic and Wegovy, revealing that the Senate Committee…
All articles by Justine Ra
Justine Ra
Justine Ra is a healthcare reporter for Clinical Trials Arena and Pharmaceutical Technology, focusing coverage on neurology and neurodegenerative diseases. Justine holds a degree in English from The University of Michigan, Ann Arbor.
-
-
EC approves BeiGene’s tislelizumab for three NSCLC indications
BeiGene has announced that its anti-programmed cell death protein 1 (PD-1) monoclonal antibody, tislelizumab, has gained European Commission (EC) approval…
-
Alvotech moves to bring its Humira biosimilar to US market
Hot on the heels of a US Food and Drug Administration (FDA) approval for Alvotech and Teva Pharmaceuticals’ Simlandi (adalimumab-ryvk),…
-
IGM and Sanofi collaboration will pivot to immunology and inflammation
IGM Biosciences has announced that the focus of its exclusive worldwide collaboration agreement with Sanofi will now shift to developing…
-
Marinus fails to meet early stopping criteria for status epilepticus trial
Marinus Pharmaceuticals has announced that its pivotal Phase III RAISE study (NCT04391569) of IV ganaxolone for the treatment of status…
-
Rallybio and J&J collaborate to tackle maternal-foetal blood disorder
Rallybio has announced a collaboration with the pharma giant to advance complementary therapeutic solutions for foetal and neonatal alloimmune thrombocytopenia…
-
Pfizer meets Phase III primary endpoints for RSV vaccine Abrysvo
Pfizer has reported positive top-line results from its Phase III MONeT study (NCT05842967) evaluating the efficacy of single-dose Abrysvo for…
-
AstraZeneca reports positive Phase III results for Imfinzi in small cell lung cancer
Though a recent Phase III trial failed to achieve its primary endpoint with Imfinzi (durvalumab) in a specific subset of…
-
Morris & Dickson will distribute mpox vaccine Jynneos in the US
Following Bavarian Nordic’s announcement of the US commercial launch of its mpox (monkeypox) vaccine Jynneos (Imvanex/Imvamune), Morris & Dickson has…
-
Eisai and Biogen move to bring IV maintenance dosing for Leqembi to the US
As Eli Lilly’s plans for its Alzheimer’s medication donanemab get delayed, Eisai has submitted a supplemental Biologics License Application (sBLA)…